Form D · Other
Merieux Nutrisciences Corp
Chicago, IL · CIK 0001564918
Offering snapshot reported Jan 2, 2013 · SEC filing
- Reported sold
- $35M Offering amount: $35M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Dec 20, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 2, 2013 | Initial | $35,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-189310
Source: Form D, filed Jan 2, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tiziano Conte | Director |
| Russell Flowers | Director |
| Benoit Habert | Director |
| Philippe Marcel | Director |
| Christopher A. Mc Vety | Executive |
| Alexandre Merieux | Director |
| Alain Merieux | Director |
| Philippe Sans | Director, Executive |
| Sebastien Schneider | Executive |
| Dominique Takizawa | Director |
| Alvaro Vargas | Director |
| Roland Vaxelaire | Director |
Issuer details
Industry: Other (See others in industry)
Address:
111 E. Wacker Dr.
Chicago, IL, 60601
Chicago, IL, 60601